This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Ronni Aram: Innovator in Cancer Research
Introduction
Ronni Aram is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cancer research, particularly in understanding and modulating tumor metastasis. His work focuses on innovative methods to combat cancer progression, showcasing his dedication to improving patient outcomes.
Latest Patents
Ronni Aram holds a patent titled "Modulators of human KAI1 metastasis suppressor gene, methods and uses thereof." This invention provides modulators of human cancer and tumor metastasis, specifically targeting SKAI1BC, an antisense long non-coding RNA. This RNA has been identified as an epigenetic suppressor of the metastasis suppressor gene KAI1/CD82. The patent outlines compositions, methods, and uses aimed at decreasing metastasis, invasion, and potentially the proliferation of cancer cells. He has 1 patent to his name.
Career Highlights
Aram is affiliated with Tel Aviv University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer treatment and understanding the mechanisms behind metastasis.
Collaborations
Some of his notable coworkers include Pnina Gottfried Komlosh and Dan Canaani, who have collaborated with him on various research projects.
Conclusion
Ronni Aram's innovative work in cancer research exemplifies the importance of scientific inquiry in addressing complex health challenges. His contributions continue to pave the way for advancements in cancer treatment and understanding metastasis.